Home
    • Plans Blog Contact
    Avantor, Inc. logo

    Avantor, Inc.

    AVTR
    Last price US$11.76
    Market cap US$7.1b
    12M price change -17.24%
    Loading the 12-month Mave Thesis and 1-month news signal

    Industry and sector peers, plus broader research alternatives

    View comparison
    Linde PLCLIN Industry peer NEWMARKET CORPNEU Industry peer Sherwin-Williams CoSHW Industry peer Apple IncAAPL Research alternative
    Overview Earnings Report Price History News Competitors Earnings per Share Return on Equity Net Margin Share Buyback Leverage Financial Statements Financial Ratio
    Dashboard Funda..tals Prediction Screener Map

    Avantor, Inc. Overview

    Industry: Specialty Chemicals

    Sector: Basic Materials

    Avantor, Inc. engages in the provision of mission-critical products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Further, it provides logistics, chemical and equipment tracking, and glassware autoclaving, as well as scientific research support services, such as DNA extraction, bioreactor servicing, clinical and biorepository, and compound management services. Avantor, Inc. was founded in 1904 and is headquartered in Radnor, Pennsylvania. Avantor, Inc. engages in the provision of mission-critical products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consu Read More

    Mavefund brings filings, fundamentals, valuation, price history and news for Avantor, Inc. into one research view. The sections below show what strengthens or weakens the research case.

    Score

    Reported Results

    What the company reported, with filing details kept small.

    Filed Apr 29, 2026

    Quarterly result summary

    Net sales was $1,581M (reported); EPS was $0.17 (reported).

    Net sales $1,581M reported
    EPS $0.17 reported
    Operating income $99.5M reported
    Net loss -$551.4 reported

    What changed

    • Net sales reported to $1,581M; EPS reported to $0.17.
    • Capital return update: free cash flow $25M.
    • Net sales of $1,581 million.

    Guidance / outlook

    No formal outlook was extracted from this filing excerpt. Open the SEC source to review full management commentary.

    Earnings release Open filing

    Source: SEC EDGAR company-filed earnings materials. Dates are shown only for verification; review the source filing before relying on extracted report details.

    Other recent earnings materials
    SEC filing 8-K Apr 29, 2026 SEC filing 10-Q Apr 29, 2026 Earnings release Earnings release Feb 11, 2026 SEC filing 8-K Feb 11, 2026 SEC filing 10-K Feb 11, 2026 SEC filing 10-Q Oct 29, 2025 SEC filing 8-K Oct 29, 2025 Earnings release Earnings release Oct 29, 2025 SEC filing 10-Q Aug 01, 2025 SEC filing 8-K Aug 01, 2025 Earnings release Earnings release Aug 01, 2025

    Prediction-grade evidence

    Recent News

    Company-relevant articles from sources that pass the Mave Signal relevance and reliability checks.

    Earnings Per Share

    Score 4.00/5
    Avantor, Inc. boasts a high score, as its Earnings Per Share (EPS) has demonstrated consistent growth over the past six years. Notable counterparts in the sector with high scores includes Linde PLC NEWMARKET CORP Sherwin-Williams Co
    In Specialty Chemicals industry , Linde PLC , NEWMARKET CORP , Sherwin-Williams Co are companies with high ratings.

    Return on Equity

    Score 2.00/5
    Avantor, Inc. exhibits a lower score in the Return on Equity (ROE) section, falling below the sector median value and indicating a comparatively weaker performance in this metric. The top companies in the same sector include Linde PLC NEWMARKET CORP Sherwin-Williams Co
    Avantor, Inc... AVTR US$7.1b
    Linde PLC LIN US$246.2b
    NEWMARKET CO... NEU US$7.0b
    Sherwin-Will... SHW US$82.8b

    Net Margin

    Score 3.94/5
    Avantor, Inc. commands a high score, propelled by its net margin consistently outpacing the sector median value and exhibiting continuous growth in recent six years; noteworthy counterparts in the sector, boasting similarly high scores, include Linde PLC NEWMARKET CORP Sherwin-Williams Co
    Avantor, Inc... AVTR US$7.1b
    Linde PLC LIN US$246.2b
    NEWMARKET CO... NEU US$7.0b
    Sherwin-Will... SHW US$82.8b

    Share Buyback

    In Specialty Chemicals industry , Linde PLC , NEWMARKET CORP , Sherwin-Williams Co are companies with high ratings.

    Leverage

    Score 1.48/5
    Avantor, Inc. registers a lower score in the category as a result of its elevated leverage ratio over the past six years compared to the sector median value. Conversely, other companies in the same sector, including Linde PLC NEWMARKET CORP Sherwin-Williams Co have achieved high scores.
    Avantor, Inc... AVTR US$7.1b
    Linde PLC LIN US$246.2b
    NEWMARKET CO... NEU US$7.0b
    Sherwin-Will... SHW US$82.8b

    Financial Statements

    Company-reported SEC EDGAR facts organized into the three core statements.

    Verified SEC statements load when this section enters view.

    Source: SEC EDGAR companyfacts. Values are standardized company filings for research support, not personalized financial advice.

    Financial Ratio

    Yearly Quarterly

    Financial
    Profitability
    Growth
    Cash Flow
    Financial Health
    Efficiency Ratios

    Avantor, Inc. logo

    Avantor, Inc.

    US$11.76

    US$6.16

    -46.1% vs price

    US$7.1b

    10.22%

    -17.24%